AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) revenue for the last year amounted to 107.40 M USD, the most of which — 73.80 M USD — came from its highest performing source at the moment, Aytu Bioscience, the year earlier bringing 61.12 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) 106.92 M USD, and the year before that — 94.61 M USD.